Cns Pharmaceuticals Inc (NASDAQ: CNSP) closed the day trading at $0.22 down -13.38% from the previous closing price of $0.26. In other words, the price has decreased by -$0.0360 from its previous closing price. On the day, 794354 shares were traded.
Ratios:
For a better understanding of CNSP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.23 and its Current Ratio is at 0.23.
On August 24, 2020, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 01 ’24 when Climaco John M bought 166,666 shares for $0.30 per share. The transaction valued at 50,000 led to the insider holds 215,676 shares of the business.
Downs Christopher bought 66,666 shares of CNSP for $20,000 on Feb 01 ’24. The Chief Financial Officer now owns 103,438 shares after completing the transaction at $0.30 per share. On Feb 01 ’24, another insider, Evans Carl Anthony, who serves as the Director of the company, bought 33,333 shares for $0.30 each. As a result, the insider paid 10,000 and bolstered with 33,458 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNSP now has a Market Capitalization of 1.89M and an Enterprise Value of 1.64M.
Stock Price History:
Over the past 52 weeks, CNSP has reached a high of $4.40, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is 0.3211, while the 200-Day Moving Average is calculated to be 1.3540.
Shares Statistics:
Over the past 3-months, CNSP traded about 419.78K shares per day on average, while over the past 10 days, CNSP traded about 220.89k shares per day. A total of 10.63M shares are outstanding, with a floating share count of 10.14M. Insiders hold about 4.70% of the company’s shares, while institutions hold 3.15% stake in the company. Shares short for CNSP as of Mar 15, 2024 were 103.79k with a Short Ratio of 0.25, compared to 102.55k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.23% and a Short% of Float of 1.24%.
Earnings Estimates
Current recommendations for the stock of the company come from 0 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
